This review summarizes the fabrication and clinical application of OCP/Col as a bone substitute material, indicating its potential.
Octacalcium phosphate (OCP), a precursor to hydroxyapatite (HA), has recently garnered significant interest from biomaterial researchers both domestically and internationally because OCP has been confirmed to possess the capacity to activate bone-related cells, such as osteoblasts and osteoclasts, and to exhibit high osteogenic potential and bioresorbability if implanted in bone defects. Since OCP contains a large amount of water molecules in its structure, it cannot be sintered as a single crystal phase. Therefore, efforts have been paid to develop molding OCP through combining polymer materials, such as collagen (Col). OCP/Col has been approved in Japan for clinical application as a bone substitute material for combination uses with dental implants in the oral and maxillofacial surgery fields. The aim of this review is to summarize the process leading to the OCP/Col fabrication, as well as the clinical application of OCP/Col, focusing on these materials from chemical, physical, and biological perspectives as biomaterials.
No takes yet. Share an insight, caveat, or question.
SUZUKI et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: